587 results on '"Menéndez, Rosario"'
Search Results
2. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
3. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
4. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)
5. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
6. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
7. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia
8. Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study
9. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
10. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection
11. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
12. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
13. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
14. Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
15. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
16. Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term Mortality
17. Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
18. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study
19. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
20. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort
21. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
22. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection
23. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
24. RIBRON: The Spanish online bronchiectasis registry. Characterization of the first 1912 patients
25. RIBRON: el registro español informatizado de bronquiectasias. Caracterización de los primeros 1.912 pacientes
26. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
27. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
28. Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia
29. Eventos cardiovasculares tempranos y tardíos en pacientes ingresados por neumonía adquirida en la comunidad
30. Neumonía adquirida en la comunidad. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
31. Neumonía intrahospitalaria. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
32. Pathophysiology, Immunology, and Histopathology of Bronchiectasis
33. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
34. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
35. Pneumonia
36. Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers
37. Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis
38. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality
39. An international perspective on hospitalized patients with viral community-acquired pneumonia
40. Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia.
41. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
42. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis
43. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
44. Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections
45. Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences
46. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia
47. A blood-based microRNA signature for the early prediction of the respiratory sequelae in critical COVID-19
48. A plasma microRNA panel strengthens the early prediction of ICU mortality: A multicenter COVID-19 study
49. Persistence of lung dysfunction in post-acute COVID-19: a microRNA approach
50. Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case–Control Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.